The American Society for 

Reproductive Immunology 


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Society for Reproductive Immunology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Amedco LLC designates this LIVE activity for a maximum of 36.5 AMA PRA Category 1 CreditsTM

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


At the conclusion of the meeting, all participants should be able to:

  1. Summarize recent advances in understanding of mechanism of action and potential interventions including vaccines to combat infections of the reproductive tract.
  2. Explain new and novel technologies in the field of reproductive immunology that permit access to early in utero environment.
  3. Evaluate the latest cutting edge research to understand developmental origins of adult health.
  4. Value being an active participant in making the academic environment more equitable and inclusive.

Satisfactory Completion

Participants must attend sessions and complete an evaluation survey to receive a certificate of completion. Partial credit of individual sessions is not available. NOTE: It is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

How are credits calculated?

A maximum of 36.5 credits may be earned during the 2023 meeting.  *1 CME credit = 1 hour of educational content.  

Credits are broken down as follows:

 Session TypeTotal # Hours 
 Pre-Meeting Clinical Course10.0 
 Plenary/Keynote/Presidential Sessions 3.0 
 Gusdon Award Session1.5 
 Herr & AJRI award lectures (0.5 each)1.0 
 Breakout/Concurrent Sessions (18)18.0 
 Poster Session 1.5 
 Lunch Sessions (Mon & Wed) 1.5 each3.0 

Claiming CME Credits

CME certificates will be available for attendees who participate in live sessions.  At the conclusion of the meeting, you will be able to claim your certificate for the sessions you attended.  

Disclosure of Conflict of Interest

All individuals in a position to control the content of CE are listed below. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.

 Name  Commercial Interest: Relationship
 Kristina Adams Waldorf
 Marianna Alperin
Renovia, Inc:Scientific/Medical Advisory Board Member
NIH:Research Grant Overall Principal Investigator
 Kang Chen
RHIA Ventures:Consultant
 Michael Citron
Merck and Co. Inc:Employee & Stock Shareholder
 Maged Constantine
Siemens Healthcare, AMAG Pharmaceuticals, Baxter Healthcare:Research Grant Site Principal Investigator
 Kristen Demoruelle
Pfizer, Boehringer Ingelheim:Research Grant Overall Principal Investigator
 Craig Hendriz
Gilead Sciences, Merck:Research Grant Site Principal Investigator
Prionde Biopharma, LLC:Scientific/Medical Advisory Board Member
 Melissa Herbst-Kralovetz
 Vaginal Biome Science:Consultant
Freya Bioscience:Scientific/Medical Advisory Board Member
 Jun Huh
CJ Jeiljedang, Interon laboratories:Consultant
CJ bioscience:Research Grant Site Principal Investigator
 Amir Jazaeri
Green Fire Bio, Avenge Bio:Stock Shareholder
Iovance, Merck, AstraZeneca, Macrogenics, Eli Lilly:Research Grant Site Principal Investigator
Macrogenics, Adicet Bio, Immatics, Theolytics, Virogin:Scientific/Medical Advisory Board Member
 S. Ananth Karumanchi
Aggamin:Private Stock Shareholder
 David MacIntyre
Freya Biosciences:Scientific/Medical Advisory Board Member
 Caroline Mitchell
Scynexis, Ferring Pharmaceuticals:Consultant
Scynexis:Research Grant Site Principal Investigator
 David Olson
Livmor Biosciences, Maternica Therapeutics:Owner
 Anna Powell

Diversity & Inclusion: Our Foundation for Scientific Innovation

Many of the greatest ideas and discoveries come from a diverse mix of minds, backgrounds and experiences, and we are committed to cultivating an inclusive work environment. ASRI provides equal opportunities to all members and applicants for awards without regard to race, religion, color, age, sex, national origin, sexual orientation, gender identity, genetic disposition, neurodiversity, disability, veteran status or any other protected category under federal, state and local law.

Copyright © 2020 ASRI
Powered by Wild Apricot Membership Software